Michael A. Davies

Development of a robust classifier for quality control of reverse-phase protein arrays

John N. Weinstein, Wenbin Liu, Kevin R. Coombes, 2015, Bioinform..

The Many Flavors of DIPS: A History and an Overview

Michael A. Davies, Dan Basco, 2010 .

Resistance to BRAF Inhibition in BRAF-Mutant Colon Cancer Can Be Overcome with PI3K Inhibition or Demethylating Agents

Michael A. Davies, Gordon B. Mills, John M. Mariadason, 2012, Clinical Cancer Research.

ALK Fusion Partners Impact Response to ALK Inhibition: Differential Effects on Sensitivity, Cellular Phenotypes, and Biochemical Properties

Michael A. Davies, C. Lovly, Huiqin Chen, 2018, Molecular Cancer Research.

Phase I Study of the Combination of Sorafenib and Temsirolimus in Patients with Metastatic Melanoma

Michael A. Davies, Chaan S. Ng, Roland L. Bassett, 2012, Clinical Cancer Research.

Pathways and therapeutic targets in melanoma

Michael A. Davies, Moshe Oren, David E. Fisher, 2014, Oncotarget.

Somatic mutations in MAP3K5 attenuate its pro-apoptotic function in melanoma through increased binding to Thioredoxin

Stephen C. J. Parker, Jeffrey E. Gershenwald, Xiaomu Wei, 2013, The Journal of investigative dermatology.